Oklo To Advance Groves Isotope Production Facility As Part Of US DOE’s National Reactor Innovation Center Nuclear Energy Launch Pad Initiative

• U.S. Department of Energy’s National Reactor Innovation Center picks 12 developers on 13 new projects to take part in the Nuclear Energy Launch Pad initiative.
• Oklo plans to build on the rapid deployment of the Groves Isotope Test Reactor in Texas with Groves 2 Forge, an isotope production and processing pilot facility.
• Groves 2 Forge to initially focus on producing lutetium-177, an isotope used in targeted cancer treatments.
• Oklo plans to transition Groves 2 Forge from pilot operations to commercial-scale isotope production with the appropriate U.S. Nuclear Regulatory Commission licenses for commercial operation.

Oklo Inc. (NYSE:OKLO) ("Oklo" or "the Company"), an advanced nuclear technology company, today announced it would advance the Groves isotope production facility (Groves 2 Forge) as part of the U.S. Department of Energy’s (DOE’s) National Reactor Innovation Center (NRIC) Nuclear Energy Launch Pad initiative. Through the initiative, Oklo’s Groves 2 Forge will build on the demonstration experience from Oklo’s Groves Isotope Test Reactor while including capabilities to produce, process, and purify critical isotopes.